Office of Research
Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM1 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit grant applications that propose to establish Consortia for HIV/AIDS Vaccine Development (CHAVD) to support a coordinated, multidisciplinary team(s) of researchers focused on iterative approaches to accelerate HIV vaccine development by addressing key immunogen design roadblocks to the discovery and development of a safe and effective antibody-mediated preventive HIV vaccine.
Application Instructions
Please submit:
- a 3-page letter of intent with a description of proposed aims and approach, and a description of proposed consortium members
- Biosketch or CV of the PI
to research@uw.edu by 5:00 PM Thursday, March 29, 2018. Proposals are due to the sponsor 6/28/18, so you will need to have your materials in to OSP by 6/20/18 for processing, if given the go-ahead by the review committee.
Inquiries and Contact Information
Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.
For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.